Voyager Therapeutics's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Voyager Therapeutics is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is €-0.41. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 90.06M	$ 4.61M	$ 4.85M	$ 150.48M	$ -1.55M
Gross Profit	$ 90.06M	$ 4.61M	$ 4.85M	$ 150.48M	$ -1.55M
EBIT	$ 57.22M	$ -26.08M	$ -22.15M	$ 122.88M	$ -24.61M
EBITDA	$ 56.72M	$ -26.94M	$ -21.07M	$ 123.94M	$ -23.76M
Net Income Common Stockholders	$ 56.40M	$ -25.90M	$ -22.21M	$ 124.04M	$ -23.63M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 230.88M	$ 252.94M	$ 272.75M	$ 273.31M	$ 118.85M
Total Assets	$ 351.28M	$ 294.65M	$ 315.54M	$ 336.29M	$ 159.36M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -230.88M	$ -252.94M	$ -272.75M	$ -273.31M	$ -118.85M
Total Liabilities	$ 114.96M	$ 118.43M	$ 116.51M	$ 119.33M	$ 100.34M
Stockholders Equity	$ 236.32M	$ 176.22M	$ 199.00M	$ 216.96M	$ 59.02M
Cash Flow	-
Free Cash Flow	$ -24.52M	$ -21.83M	$ -2.04M	$ 123.06M	$ -13.18M
Operating Cash Flow	$ -23.76M	$ -21.05M	$ -835.00K	$ 123.56M	$ -12.24M
Investing Cash Flow	$ 26.83M	$ -158.30M	$ -24.66M	$ 14.49M	$ 14.07M
Financing Cash Flow	$ 460.00K	$ 331.00K	$ 1.55M	$ 31.31M	$ 276.00K

Currency in USD

Voyager Therapeutics Earnings and Revenue History

Income Statement >

Voyager Therapeutics Debt to Assets

Balance Sheet >

Voyager Therapeutics Cash Flow

Cash Flow >

Voyager Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing